Jove
Visualize
Contact Us

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Rat and dog quad-culture liver chip models: characterization and use to interrogate a potential flavin-containing monooxygenase-mediated, species-specific toxicity of a histamine receptor antagonist.

Toxicological sciences : an official journal of the Society of Toxicology·2025
Same author

Application of new approach methodologies for nonclinical safety assessment of drug candidates.

Nature reviews. Drug discovery·2025
Same author

Enabling novel paradigms: a biological questions-based approach to human chemical hazard and drug safety assessment.

Toxicological sciences : an official journal of the Society of Toxicology·2023
Same author

Perspectives on the evaluation and adoption of complex in vitro models in drug development: Workshop with the FDA and the pharmaceutical industry (IQ MPS Affiliate).

ALTEX·2022
Same author

Opinion on the Use of Animal Models in Nonclinical Safety Assessment: Pros and Cons.

Toxicologic pathology·2021
Same author

Publication Categories in <i>Toxicologic Pathology</i>.

Toxicologic pathology·2021
Same journal

Immunohistochemical detection of the transcription factor osterix in canine and feline osteosarcoma.

Veterinary pathology·2026
Same journal

Spontaneous rhabdomyosarcomas in <i>Dmd</i><sup><i>mdx</i></sup> rats.

Veterinary pathology·2026
Same journal

Data set creation for supervised deep learning-based analysis of microscopic images: Review of important considerations and recommendations.

Veterinary pathology·2026
Same journal

Reporting transparency in veterinary pathology deep learning: A systematic review of reproducibility-critical details.

Veterinary pathology·2026
Same journal

Magnetic resonance imaging of primary central nervous system neoplasms of dogs and cats: Basic concepts for diagnostic pathologists.

Veterinary pathology·2026
Same journal

Fatal enteric disease reproduced in guinea pigs by oral administration of pollen beetle (<i>Astylus atromaculatus</i>).

Veterinary pathology·2026
See all related articles
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Video

Updated: Dec 26, 2025

Intact Histological Characterization of Brain-implanted Microdevices and Surrounding Tissue
11:31

Intact Histological Characterization of Brain-implanted Microdevices and Surrounding Tissue

Published on: February 11, 2013

17.2K

Microphysiological Systems: A Pathologist's Perspective.

Radhakrishna Sura1, Terry Van Vleet1, Brian R Berridge2

  • 1Global Preclinical Safety, AbbVie Inc, North Chicago, IL, USA.

Veterinary Pathology
|March 18, 2020
PubMed
Summary
This summary is machine-generated.

Microphysiological systems (MPS), or organs-on-chips, offer advanced in vitro modeling for drug discovery. Early pathologist involvement is key to developing more predictive and human-relevant MPS models.

Keywords:
alternativebiomarkercell culture techniquesdrug developmentin vitroinduced pluripotent stem cellsmicrophysiological systemmodelorgan on a chipsafety assessment

More Related Videos

Industrialized, Artificial Intelligence-guided Laser Microdissection for Microscaled Proteomic Analysis of the Tumor Microenvironment
13:01

Industrialized, Artificial Intelligence-guided Laser Microdissection for Microscaled Proteomic Analysis of the Tumor Microenvironment

Published on: June 3, 2022

4.4K
Morphology-Based Distinction Between Healthy and Pathological Cells Utilizing Fourier Transforms and Self-Organizing Maps
08:59

Morphology-Based Distinction Between Healthy and Pathological Cells Utilizing Fourier Transforms and Self-Organizing Maps

Published on: October 28, 2018

7.5K

Related Experiment Videos

Last Updated: Dec 26, 2025

Intact Histological Characterization of Brain-implanted Microdevices and Surrounding Tissue
11:31

Intact Histological Characterization of Brain-implanted Microdevices and Surrounding Tissue

Published on: February 11, 2013

17.2K
Industrialized, Artificial Intelligence-guided Laser Microdissection for Microscaled Proteomic Analysis of the Tumor Microenvironment
13:01

Industrialized, Artificial Intelligence-guided Laser Microdissection for Microscaled Proteomic Analysis of the Tumor Microenvironment

Published on: June 3, 2022

4.4K
Morphology-Based Distinction Between Healthy and Pathological Cells Utilizing Fourier Transforms and Self-Organizing Maps
08:59

Morphology-Based Distinction Between Healthy and Pathological Cells Utilizing Fourier Transforms and Self-Organizing Maps

Published on: October 28, 2018

7.5K

Area of Science:

  • Biomedical Engineering
  • Drug Discovery
  • Toxicology

Background:

  • Current in vitro models lack human-relevant complexity, limiting their predictive power for in vivo responses.
  • Microphysiological systems (MPS) aim to improve in vitro modeling for research and drug development.
  • Existing MPS models often lack full characterization of cellular complexity and attributes.

Purpose of the Study:

  • To provide an overview of microfluidic MPS (organs-on-chips) capabilities and limitations in drug development.
  • To highlight the importance of interdisciplinary collaboration in developing reliable MPS.
  • To recommend strategies for enhancing MPS model predictivity.

Main Methods:

  • Review of microfluidic microphysiological systems (MPS) for drug development.
  • Analysis of current MPS capabilities and limitations.
  • Discussion of the role of pathologists in MPS development.

Main Results:

  • MPS represent a significant advancement over traditional in vitro models.
  • Incomplete characterization of cellular complexity and attributes is a key limitation of current MPS.
  • Early engagement of pathologists can improve MPS model robustness.

Conclusions:

  • Microfluidic MPS offer revolutionary potential for in vitro modeling in drug discovery.
  • Pathologist involvement is crucial for developing comprehensive and predictive MPS models.
  • Enhanced MPS models can more accurately replicate human biology and pathophysiology, improving response prediction.